CSPC Pharma (01093) announced quarterly results
- RevenueRMB185.9bn
- Net profitRMB64.6bn
- Profit attributable to ownersRMB60.9bn
- Revenue YoY+40.1%
- Net profit YoY+151.0%
- Depreciation & amortisationHK$14.1bn
- Capital expenditureHK$-22.8bn
- Interest-bearing debtHK$6.4bn
Source CSPC Pharma




